Global Skin Graft Market, By Type (Allogeneic, Autologous, Xenogeneic, Prosthetic, Isogeneic), Graft Thickness (Split-Thickness, Full-Thickness, Composite Graft), Application (Burns, Extensive Wound, Skin Cancer, Infection), Equipment Type (Dermatome, General Surgical Instruments, Consumables, Others), End-User (Ambulatory Surgical Centres, Hospitals, Dermatology Clinics, Academic and Research, Others) – Industry Trends and Forecast to 2030.
Skin Graft Market Analysis and Size
A skin graft is defined as the extraction of donor skin from a separate body part/donor site of the patient, which is then transplanted to the required site to complete the skin grafting procedure. This procedure involves the extraction of skin that is usually hidden from view or covered, and it is used to reverse or reduce the complications caused by burns, various skin-based disorders, injuries, and various other complications.
Data Bridge Market Research analyzes that the skin graft market which was USD 1,193.13 million in 2022, is expected to reach USD 2,540.23 million by 2030, and is expected to undergo a CAGR of 9.97% during the forecast period of 2023 to 2030. “Allogeneic” dominates the type segment of the skin graft market due to rising demand of skin graft. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Allogeneic, Autologous, Xenogeneic, Prosthetic, Isogeneic), Graft Thickness (Split-Thickness, Full-Thickness, Composite Graft), Application (Burns, Extensive Wound, Skin Cancer, Infection), Equipment Type (Dermatome, General Surgical Instruments, Consumables, Others), End-User (Ambulatory Surgical Centres, Hospitals, Dermatology Clinics, Academic and Research, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America
|
|
Market Players Covered
|
Smith & Nephew Plc (U.K.), MiMedx (U.S.), Tissue Regenix (U.K.), Integra LifeSciences Corporation (U.S.), Organogenesis Inc. (U.S.), Zimmer Biomet (U.S.), NOUVAG AG (Switzerland), De Soutter Medical (U.K.), Mallinckrodt (U.K.), B. Braun Melsungen AG (Germany), AVITA Medical (U.K.), Surtex Instruments Limited (U.K.), Exsurco Medical, Inc. (U.S.), Specmed (Poland), ConvaTec Inc. (U.K.), CryoLife, Inc. (U.S.), Athersys Inc. (U.S.), LifeNet Health (U.S.), U.S. Stem Cell, Inc. (U.S.), Isto Biologics (U.S.), Allergan (U.S.)
|
|
Market Opportunities
|
|
Market Definition
A skin graft is a surgical procedure in which a piece of healthy skin is taken from one area of the body (donor site) and transplanted to another area (recipient site) that has lost its skin due to injury, burns, or other conditions. The transplanted skin serves as a replacement for the damaged or missing skin, aiding in wound healing and promoting tissue regeneration. Skin grafts can vary in thickness, and they help restore the skin's protective function and improve its appearance.
Global Skin Graft Market Dynamics
Drivers
- Rising cases of chronic wounds
The growing incidence of chronic wounds, including diabetic ulcers, pressure sores, and venous leg ulcers, is a major driver of the skin graft market. Chronic wounds are a significant burden on healthcare systems and patients alike. Skin grafts are often employed to facilitate wound closure, improve healing, and prevent infections. With chronic wound cases on the rise, the demand for skin grafts is expected to increase. Skin grafts, particularly autografts and allografts, play a crucial role in the treatment of chronic wounds. They promote healing by providing a protective barrier, enhancing tissue regeneration, and reducing the risk of complications. The rise in diabetes and related conditions contributes to an increased prevalence of chronic wounds, making skin grafts an essential part of modern wound care.
- Advancements in grafting technologies
Advancements in grafting technologies are significantly driving the skin graft market. These technologies encompass both the graft materials and the techniques used for transplantation. Innovations in graft materials, such as the development of synthetic skin substitutes, have expanded the range of options available for healthcare professionals. Synthetic skin substitutes have emerged as an exciting development. They often mimic the structure and function of natural skin, making them effective for wound coverage and healing. These substitutes are designed to promote tissue regeneration and reduce the risk of graft rejection. Moreover, they address concerns related to the limited availability of donor sites, which is a constraint in traditional grafting. In addition, the improvement in grafting techniques, such as laser-assisted grafting and tissue engineering, has enhanced the success rate of skin graft procedures. Laser technology allows for precision in graft removal and preparation, reducing the risk of graft damage and failure. Tissue engineering techniques help create customized grafts using a patient's own cells, further reducing the likelihood of rejection.
- Rising cases of skin diseases
The increase in skin diseases, including skin cancer and dermatological conditions, is another driver of the skin graft market. Patients with extensive skin damage due to diseases often require grafts to repair and replace damaged tissue. The rise in the prevalence of skin diseases expands the demand for skin grafts for both medical and cosmetic reasons. Autografts, in particular, are widely used in dermatological applications. They help reconstruct damaged skin areas following surgical excisions of skin cancer or the treatment of burns. Skin grafts can not only restore appearance but also prevent functional impairments that might arise from the loss of skin tissue. The rising awareness of the importance of early skin disease detection and treatment underscores the need for effective skin grafting solutions. As more people seek medical intervention for skin conditions, the market for skin grafts is expected to grow.
Opportunities
- Rapid advancements in tissue engineering
The rapid advancements in tissue engineering present a significant opportunity in the skin graft market. Tissue engineering techniques are becoming more sophisticated and offer the potential to create custom grafts using a patient's own cells. This personalized approach can significantly reduce the risk of graft rejection and improve grafting outcomes. Moreover, tissue engineering is exploring the development of bioactive scaffolds, which can enhance tissue regeneration and offer long-term benefits. Customized grafts created using tissue engineering techniques can match the patient's anatomy, improving both function and aesthetics. The opportunity lies in making tissue engineering solutions more widely available and streamlining the processes for graft customization.
- Expansion of grafting services
The expansion of grafting services into underserved regions and communities represents a significant opportunity. Many people in developing regions or remote areas lack access to advanced grafting procedures. Expanding grafting services can address unmet healthcare needs and improve the quality of care for a broader population. This opportunity requires collaboration among healthcare organizations, non-governmental organizations (NGOs), and governments to provide grafting services to underserved regions. Mobile medical units and telemedicine solutions can also play a vital role in expanding grafting services to remote communities.
Restraints/Challenges
- High cost of skin graft procedures
The high cost associated with skin graft procedures serves as a significant restraint in the skin graft market. Skin grafting can be an expensive medical intervention due to the surgical procedure itself, the graft material, and the need for specialized medical expertise. The cost factor can limit access to skin graft procedures, especially for patients without adequate insurance coverage or financial resources. This restraint is particularly relevant for developing regions where healthcare resources are limited, and patients may not afford the procedure. Addressing this restraint involves exploring cost-effective grafting solutions, promoting insurance coverage for necessary grafting procedures, and making skin grafts more accessible to a broader population.
-
Limited availability of donor sites
The limited availability of donor sites is a restraint specific to autografts. Autografts, while having a lower risk of graft rejection, often require a donor site from the patient's body. This donor site is typically healthy skin that can be used to harvest grafts for transplantation. The challenge is that donor sites are limited, and grafting from these sites can lead to scarring, complications, and further wound sites. The restraint of limited donor sites can be particularly relevant for patients who require extensive grafting procedures or who have multiple medical conditions requiring grafts. Addressing this restraint involves the development of synthetic skin substitutes and alternative graft materials that can reduce the need for autografts. These alternatives can provide effective grafting solutions while preserving the limited donor sites.
This skin graft market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the skin graft market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In April 2023, Kerecis has announced MariGen Shield, which integrates the company’s proven fish-skin graft with a silicone contact layer for treating chronic and complex wounds. The medical-fish-skin company also announced the results of a clinical study comparing the effectiveness of the Kerecis fish-skin grafts to a standard of care for diabetic foot ulcers. This has helped the company to expand its product portfolio
Global Skin Graft Market Scope
The skin graft market is segmented on the basis of type, graft thickness, application, equipment type and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Allogeneic
- Autologous
- Xenogeneic
- Prosthetic
- Isogeneic
Graft Thickness
- Split-Thickness
- Full-Thickness
- Composite Graft
Application
- Burns
- Extensive Wound
- Skin Cancer
- Infection
Equipment Type
- Dermatome
- General Surgical Instruments
- Consumables
- Others
End-User
- Ambulatory Surgical Centres
- Hospitals
- Dermatology Clinics
- Academic and Research and Others
Global Skin Graft Market Regional Analysis/Insights
The skin graft market is analysed and market size insights and trends are provided by country, type, graft thickness, application, equipment type and end-user as referenced above.
The countries covered in the skin graft market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and rest of South America as part of South America
North America is expected to dominate the skin graft market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030, due of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.
Asia-Pacific on the other hand is projected to exhibit the highest growth rate in the skin graft market during the forecast period of 2023 to 2030 due to the increasing government expenditure on healthcare sector and rising technological advancements and initiatives by the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The skin graft market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for skin graft market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the skin graft market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Skin Graft Market Share Analysis
The skin graft market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to skin graft market.
Some of the major players operating in the skin graft market are:
- Smith & Nephew Plc (U.K.)
- MiMedx (U.S.)
- Tissue Regenix (U.K.)
- Integra LifeSciences Corporation (U.S.)
- Organogenesis Inc. (U.S.)
- Zimmer Biomet (U.S.)
- NOUVAG AG (Switzerland)
- De Soutter Medical (U.K.)
- Mallinckrodt (U.K.)
- B. Braun Melsungen AG (Germany)
- AVITA Medical (U.K.)
- Surtex Instruments Limited (U.K.)
- Exsurco Medical, Inc. (U.S.)
- Specmed (Poland)
- ConvaTec Inc. (U.K.)
- CryoLife, Inc. (U.S.)
- Athersys Inc. (U.S.)
- LifeNet Health (U.S.)
- U.S. Stem Cell, Inc. (U.S.)
- Isto Biologics (U.S.)
- Allergan (U.S.)
SKU-